Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products...
Praxsyn reported revenue of $66.60 million for fiscal year 2014, up 853.0% from fiscal year 2013, and net income of -$12.35 million. In Q3 2015 (the quarter ended September 30, 2015) revenue was $20.43 million, down 10.8% from a year before.
Figures from company filings; latest fiscal year ended December 31, 2014.
No profile data available.